logo

ETF Update: Hope For Health In A Bad Market?
By: Jeffrey A. Miller   Monday, July 06, 2009 8:56 AM

Vote for next session
The next market session will close:

Signals remain negative for the overall market in US equities.  There is plenty of concern about economic fundamentals and corporate profits.

We look for verification in the message from the market.  It is helpful to look at macro measures and also at individual stocks.  Sector ETF's reflect an important middle ground.  We look at each sector for the (T)rend, for (C)ycles and we add a bit of (A)nticipation.  We call this our TCA-ETF model.  It can be used to spot emerging trends, or to gain a better perspective on the overall market.  (The complete current rankings are at the end of the article, along with an explanation of our methodology).

Two Strong Themes

Our look at the overall picture leads us to continue a bearish market stance.  Thursday's employment report did not quite match our negative expectations, but if you looked at the details, it was close.  Our sector ratings show little leadership.  It is a time to hedge positions, and we are doing so.

Health stocks are a bit different.  Let us look at the Nasdaq Biotechnology Index Fund (IBB).   Here is the chart:

IBB

We normally do a profile of our featured sector.  This week  we draw upon ETF expert Don Dion who writes as follows:

IBB tracks the NASDAQ Biotechnology Index, comprising companies with at least a $200 million market cap. IBB has 123 holdings and an attractive 0.48% expense ratio. The top industry allocation in the fund is Medical-Biomedical/Gene, with a 63.29% weighting, followed by Medical-Generic Drugs and Medical-Drugs, with 11.34% and 9.63% weightings, respectively. While the fund tends to be top heavy—its largest component, Amgen (AMGN), makes up 10.77% of the fund—IBB’s components are spread throughout the capitalization spectrum. More than 43% of IBB’s holdings can be classified as either giant or large cap, while 28.5% are medium and 27.75% are small or micro. Overall, the top 10 holdings in the fund are allocated nearly 52% of the fund’s assets.

Mr. Dion explains our own perspective on ETF choices -- trying to get more diversity while finding the best sectors.  We urge readers to check out his entire article -- excellent work.

The general pattern is similar to other health sectors that are positive in our rankings.  There is a strong fundamental reason that most do not understand.  The entire health sector has been under pressure because of concern about the Obama health initiatives.  We have written about this issue, suggesting that the concern was overstated.

The evidence is emerging to support our viewpoint.  A major health initiative will not get past the 60-vote cloture threshold in Senate.  Despite the party switch by Arlen Spector and the election victory by Al Franken, there are Democrats missing in action due to health reasons.  There are also some Democrats who do not buy into the big proposals.

Some have speculated about an end run by the Dems, slipping through a health initiative via the budget reconciliation process.  This method would only require a simple majority, but there are limitations about what sort of changes could qualify for this treatment.

Our position is described in detail in this fine article by veteran Washington observer Morton Kondracke.  He writes as follows:

If an attempt is made to pass health reform under "reconciliation" rules -- requiring just a simple majority vote -- Senate Budget Chairman Kent Conrad, D-N.D., told me, the bill would be so pared down, "you'd be left with Swiss cheese."

Read the entire article to get his full perspective, and check out our Election Stocks site for continuing coverage of the impact of politics on the markets

Weekly TCA-ETF Rankings

Our weekly ratings are from Wednesday, a day earlier than usual because of the holiday.  The performance for last week was down about 1.5%, helped by our short positions (via inverse index ETF's).  This beat the S&P 500 by about one point.

Based upon the narrow leadership and ratings on the inverse ETF's, we have continued our official bearish position in the the Ticker Sense Blogger Sentiment poll.

Here is the table for the most recent trades and current ratings as of Thursday's close:

070209

Note for New Readers

Our weekly ETF Update is designed to assist both investors and traders interested in ETF's and Sector Rotation.  Before turning to the current rankings, let us undertake a review for readers new to this series.

Our Method.  In this past article, we described our basic methodology and why we believe the rankings are useful for fundamental traders and technical traders alike.  While we urge readers to check out the entire article, the key point is that ETF's pose challenges and opportunities different from investment in individual stocks.  The fundamentals may be more difficult to assess.  Even with a good grasp on fundamental trends, there is a lot of technically-based trading in ETF's.  This means that those trading with a fundamental approach (and we do this as well) want to monitor the "hot money" moves.  Here is an article on that point.

The system synopsis. We look at Trending sectors, Cyclical Sectors, and build in an element of Anticipation for both entry and exit -- thus the name of the model, TCA-ETF.  While we do not reveal the exact methodology for spotting trends and cycles, the system is not a "black box."  The basic elements are used by many, and widely reported.  We even discuss the need for human analysis as opposed to black box trading.

We report the rankings each week, now on the weekend with a one-day delay, using the Thursday output from the model.  We monitor and trade this daily, and offer a free report (request via the email address on the top left of the site) for those interested in our weekly trading program.



(0)
No Comments
Post Comment
Name:  
Alert for new comments:
Your email:
Your Website:
Title:
Comments:
   
 
 
 
 
   
 

The above story is the opinion of the author only and it does not reflect iStockAnalyst opinion. Further, the author is not personally advising you regarding the suitability of the story for your investment needs. In no event iStockAnalyst will be liable for any loss or damage including without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from or arising out of, or in connection with the use of this information. Please consult your investment advisor before making any investment decision.
  
Advertisement
Special Offers
Partner Center
Recent Articles by Jeffrey A. Miller



Subscribe to Email Alerts rss feed or RSS feeds rss feed for articles from more than 500 contributors, press releases, SEC filings and full text news from more than four thousand sources.
Fundamental data is provided by Zacks Investment Research, market data is provided by AlphaTrade. , and Commentary and Press Releases provided by Quotemedia